Advertisement
Introduction of seven-valent and 13-valent pneumococcal conjugate vaccine correlated with a reduction in Streptococcus pneumoniae bacteremia

Post-PCV13 Drop in Streptococcus pneumoniae Bacteremia

0
As pneumococcal rates dropped, rates of E. coli, Salmonella spp, Staphylococcus aureus increased
Even one episode of severe hypoglycemia could increase the risk of cardiovascular disease or death in patients with type 2 diabetes

Just One Severe Hypoglycemia Episode May Up Mortality in T2DM

0
Researchers also found an increase in cardiovascular disease odds
Medicare patients treated by higher-spending physicians are just as likely to be re-admitted or die within 30 days of being admitted to the hospital as patients treated by doctors who order fewer or less-expensive tests and treatments

Higher Spending by Physicians Not Tied to Better Outcomes

0
No difference in patient outcomes when physicians order more -- or more pricey -- tests, treatments
For patients with type 2 diabetes

Better Outcomes in T2DM With No Delay in Tx Intensification

0
Greater reduction in HbA1c, but increased risk of severe hypoglycemia with no delay in intensification
Most primary care physicians and pulmonologists recommend use of U.S. Food and Drug Administration-approved smoking cessation medications before use of electronic cigarettes

Most Doctors Recommend FDA-Approved Drugs Before E-Cigs

0
Two-thirds of PCPs, pulmonologists recommend FDA-approved medications for smokers with asthma
Cannabis use may raise an adult's risk of stroke and heart failure

ACC: Cannabis Tied to Higher Odds for Stroke, Heart Failure

0
Cannabis associated with 26 percent increased risk of stroke, 10 percent increased risk of heart failure
Phosphodiesterase type 5 inhibitors appear to reduce a man's risk of death or heart failure after a first myocardial infarction

ACC: Erectile Dysfunction Drugs May Benefit Men’s Hearts

0
Men taking PDE5 inhibitors have reduced risk of death within three years of first MI
For patients with newly diagnosed chronic myeloid leukemia

Lasting Outcomes for Imatinib in Chronic Myeloid Leukemia

0
Estimated overall survival 83.3 percent at 10 years for patients in imatinib treatment group
For children with community-acquired pneumonia

Nonclinical Factors Drive Antibiotic Choice in Pediatric CAP

0
Age, previous antibiotic receipt, private insurance up odds of macrolide versus amoxicillin receipt
Cholesterol's impact on myocardial infarction may differ by age

ACC: Younger MI Patients More Likely to Have Low HDL, High LDL

0
Different measures may be required to accurately identify MI risk in this age group